Chetan Malik

Chetan Malik is an accomplished professional in the pharmaceutical and healthcare sectors, currently serving as the Head of Business Strategy & Commercial Operations at Alexion Pharmaceuticals, a part of AstraZeneca Rare Disease, since May 2023. Previously, Chetan held prominent roles at The Janssen Pharmaceutical Companies of Johnson & Johnson, where responsibilities included directing Patient Support Programs for Immunology and Oncology portfolios, as well as leading CX strategy and operations. Additional notable positions include Marketing Director for Oncology in Canada and Group Marketing Director for Dermatology in the US. Chetan's career began at Reliance Industries Limited as Associate Company Secretary. Educational qualifications include an MBA in Strategy and Marketing from McGill University and a Company Secretary degree from The Institute of Company Secretaries of India. Chetan also serves as a Board Member at TNO - The Neighbourhood Organization.